Clinical Trials Directory

Trials / Completed

CompletedNCT01643655

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head

Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
R-Bio · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with avascular necrosis of the femoral head.

Conditions

Interventions

TypeNameDescription
PROCEDUREAutologous Adipose Tissue derived MSCs TransplantationInto the Femoral Head infusion of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 1x10e8 cells/3mL

Timeline

Start date
2012-05-01
Primary completion
2014-12-01
Completion
2015-03-01
First posted
2012-07-18
Last updated
2017-08-31

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01643655. Inclusion in this directory is not an endorsement.

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femor (NCT01643655) · Clinical Trials Directory